Live feed
Filing
SC 13D/A
SC 13D/A0001341004-23-000148·Kymera Therapeutics, Inc.
Schedule 13D ownership disclosure
Kymera Therapeutics Inc
Security class unavailable · CUSIP: 501575104
Event date: 2023-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001341004-23-000148
- Form type
- SC 13D/A
- Filer
- Kymera Therapeutics, Inc.
- CIK
- CIK 1815442
- Filed
- Jun 05, 2023
- Reporting period
- Jun 01, 2023
- Description
- Schedule 13D beneficial ownership